Online
1 year
SEP-23
MSc - Master of Science
Medical Specialisations: P-Z Oncology
Taught
This programme gives you the foundation in molecular and cellular biology that is fundamental to cancer biology and research. You’ll study and contribute to the latest developments in curing cancer, such as novel drugs and gene therapy. You’ll also discover how new therapies are developed, evaluated and implemented.
What you'll study
This programme gives you a thorough grounding in the scientific principles underlying cancer treatment.
You’ll discover how new treatments are developed, evaluated and implemented. By the end of the course you’ll be equipped with a thorough knowledge of cancer biology and pathology, research methodologies, drug development, and regulatory issues.
You’ll have a firm grounding in the use and evaluation of cancer therapies, which will enhance your career prospects in many areas of cancer research, including early phase clinical trials.
You’ll also take a three-month dissertation under the supervision of one of our research experts. This may involve setting up a ‘mock’ clinical trial to gain experience of clinical research and drug development in the cancer setting.
Career paths
You’ll leave this programme with the clinical skills and experience necessary to pursue further academic research at PhD or MD level. This programme also provides a strong foundation if you want to work in biotech research, hospital settings or in industry.
Career destinations of past Barts Cancer Institute students include roles in higher education, the NHS and scientific publishing. Our graduates go on to jobs such as:
Each year we retain a proportion of our graduates within the Institute as PhD students, research assistants or clinical trial co-ordinators.
For this course (per year)
£12,250
For this course (per year)
£26,750
A 2:1 or above at undergraduate level in a relevant subject such as Biology, Chemistry, Pharmacology, Medicine from a recognised academic institution. Applicants with a 2:2 degree will be considered on an individual basis. The programme is open to graduate scientists, clinicians and other medical professionals working in healthcare, the pharmaceutical industry or contract research organisations.